HealthLeaders Media LIVE From UNC Health Care: Transforming Cancer Care

Bookmark and Share

HealthLeaders Media LIVE From UNC Health Care: Transforming Cancer Care

Product Code: HMK09042014

Availability: In stock

Your Price:
$399.00
each
Add Items to Cart

HealthLeaders Media LIVE From UNC Health Care: Transforming Cancer Care

Driving Outcomes and Patient Engagement Through a Multidisciplinary Model

Presented on Thursday, September 4, 2014

Webcast will be shipped in USB drive format.


As treatment options multiply and survival rates climb, cancer is increasingly being treated as a chronic condition requiring a high degree of coordination among clinical specialties. UNC Lineberger Comprehensive Cancer Center has distinguished itself as a leader in cancer treatment by adopting a multidisciplinary approach that integrates not only oncology specialties, but also mental health into the treatment program. This approach, along with Lean process improvement efforts and the incorporation of outcomes research findings, have enabled UNC Health Care to streamline treatment workflow systemwide while achieving an “exceptional” rating from the National Cancer Institute.

Order HealthLeaders Media LIVE From UNC Health Care: Transforming Cancer Care for solutions and lessons learned.
Participants will:

  • Learn the proven fundamentals of building a successful multidisciplinary, team-based, and outcomes-driven cancer care program
  • Ensure continuity of care, and reduce patient medical costs, by effectively integrating mental health considerations into treatment
  • Discover innovative ways to streamline oncological workflow and enhance communication through Lean process improvement


About our host:

UNC Lineberger Comprehensive Cancer Center is one of only 41 National Cancer Institute–designated comprehensive cancer centers. The center brings together some of the top physicians and scientists in the country to investigate and improve the prevention, early detection, and treatment of cancer. Operating from the laboratory to the bedside to the community, UNC Lineberger faculty work to understand the causes of cancer at the genetic and environmental levels, to conduct groundbreaking laboratory research, and to translate findings into pioneering and innovative clinical trials.

HealthLeaders Media LIVE From UNC Health Care: Transforming Cancer Care

HealthLeaders Media LIVE
Driving Outcomes and Patient Engagement Through a Multidisciplinary Model
Held September 9, 2014


Agenda - Learning Objectives

Lesson 1: Creating a Multidisciplinary, Team-Based, and Outcomes-Driven Cancer Program
Lesson 2:
 
Integrating Mental Health Into Cancer Care
Lesson 3: 
Developing a Focus on Lean Process Improvement and Outcomes Research in Cancer Care


Order the Webcast: HealthLeaders Media LIVE From UNC Health Care:  Transforming Cancer Care for solutions and lessons learned. Participants will:

  • Learn the proven fundamentals of building a successful multidisciplinary, team-based, and outcomes-driven cancer care program
  • Ensure continuity of care, and reduce patient medical costs, by effectively integrating mental health considerations into treatment
  • Discover innovative ways to streamline oncological workflow and enhance communication through Lean process improvement


Who Should Attend

Healthcare leaders, CEOs, CFOs, COOs, CIOs, CMOs, CNOs, cancer service line directors, directors of quality, case management, business development executives, directors of public relations/marketing, healthcare consultants

Your Faculty

Ethan Basch, MD, MSc
Director of Cancer Outcomes Research, University of North Carolina at Chapel Hill

Dr. Basch is a medical oncologist specializing in prostate cancer whose research expertise includes patient-reported outcomes, drug regulatory policy, and comparative effectiveness research. He is a member of the Methodology Committee of the Patient-Centered Outcomes Research Institute, the Board of Directors of the International Society for Quality of Life Research, Co-Chair of the Health Outcomes Committee of the Alliance for Clinical Trials in Oncology, and a member of the Board of Scientific Advisors of the National Cancer Institute. Dr. Basch holds a BA in Literature from Brown University, a Master of Philosophy (MPhil) in Literature from Oxford University, a Master of Science in Clinical Research (MSc) from Harvard School of Public Health and an MD from Harvard Medical School.

Ian B. Buchanan, MD, MPH
Associate Vice President, Oncology Service Line, UNC Health Care System

Dr. Buchanan oversees outpatient cancer services in the newly-opened North Carolina Cancer Hospital. An expert in healthcare quality improvement and administration, Dr. Buchanan previously led UNC’s Core Measures reporting efforts to CMS before accepting a position with UnitedHealth Group where he managed development and implementation of disease management and wellness programs for some of America’s largest employers. Buchanan returned to UNC in late 2008 to assume his current role.


Lisa A. Carey, MD
Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, Medical Director of the UNC Breast Center, Chief of Hematology/Oncology, and Physician-in-Chief of the N.C. Cancer Hospital

Since joining the UNC faculty and Lineberger Comprehensive Cancer Center in 1998, Dr. Carey has focused her research on the clinical application of laboratory findings in breast cancer. She designs and leads clinical trials of novel drugs and approaches, and is a close collaborator with several laboratory investigators and epidemiologists. A graduate of Wellesley College with a bachelor's degree in Biology and Art History, she received her medical degree from the Johns Hopkins University School of Medicine, where she remained for her residency in Internal Medicine followed by a fellowship in Medical Oncology and an advanced degree in Clinical Investigations. In 2011, Dr. Carey was awarded the National Cancer Institute Director's Service Award.

Lawrence Marks, MD
Dr. Sidney K. Simon Distinguished Professor of Oncology Research and Chair of the University of North Carolina Department of Radiation Oncology

A recognized expert in the treatment of patients with breast and lung cancer, Dr. Marks’ work has been aimed at improving the therapeutic ratio of radiation therapy, largely through reducing the effects of radiation on normal tissue. A national leader in studying the frequency and causes of “human errors” in the radiation oncology clinic, Dr. Marks has successfully implemented guidelines to reduce such errors and enhance patient safety. Prior to joining UNC as chair in 2008, Dr. Marks was the Banks Anderson, Sr., M.D., professor of radiation oncology at Duke University. He earned his MD at the University of Rochester and completed his residency in radiation medicine at Massachusetts General Hospital.

Meghan McCann, MSN, RN, NE-BC
Director of Oncology, North Carolina Cancer Hospital

Ms. McCann is responsible for the operations of the inpatient and outpatient clinical areas and programs at the Cancer Hospital, where she has been a member of the leadership team since 2009 and has called herself a proud Tar Heel since relocating to UNC in 2002. She holds a Master’s degree in Nursing Health Care Systems from the University of North Carolina with a Nursing Administration and Education focus, and received her Bachelor’s in Nursing from the University of Maryland and Bachelor of Arts in Biology from the College of Notre Dame of Maryland.


Donald Rosenstein, MD
Director of the UNC Comprehensive Cancer Support Program with joint appointments in the Departments of Psychiatry and Medicine, Vice-Chair for the Division of Hospital Psychiatry, Training Director for the UNC Fellowship in Psychosomatic Medicine

Dr. Rosenstein's research efforts have been focused on the interface of medicine and psychiatry, with protocols addressing: neuropsychiatric toxicity associated with the systemic administration of cytokines; the role of magnesium metabolism in mood disorders; and the assessment and management of suicidality in the medical setting. Prior to joining UNC, he was Clinical Director of the National Institute of Mental Health (NIMH) and the Chief of the Psychiatry Consultation-Liaison Service. Dr. Rosenstein is currently President of the Academy of Psychosomatic Medicine. He Dr. did his undergraduate work at Wesleyan University, received his MD from Northwestern University School of Medicine, and completed his residency in Adult Psychiatry at Yale University.